Wordt geladen...
Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice
Immunotherapy for cancer using antibodies to enhance T-cell function has been successful in recent clinical trials. Many molecules that improve activation and effector function of T cells have been investigated as potential new targets for immunomodulatory antibodies, including the tumor necrosis fa...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3975257/ https://ncbi.nlm.nih.gov/pubmed/24558202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-544742 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|